Circulating Epithelial Cells in Patients with Intraductal Papillary Mucinous Neoplasm of the Pancreas.

IPMN KRAS circulating epithelial cells circulating tumor cells intraductal papillary mucinous neoplasm liquid biomarker liquid biopsy

Journal

Life (Basel, Switzerland)
ISSN: 2075-1729
Titre abrégé: Life (Basel)
Pays: Switzerland
ID NLM: 101580444

Informations de publication

Date de publication:
15 Jul 2023
Historique:
received: 26 04 2023
revised: 03 07 2023
accepted: 11 07 2023
medline: 29 7 2023
pubmed: 29 7 2023
entrez: 29 7 2023
Statut: epublish

Résumé

Intraductal papillary mucinous neoplasm (IPMN) is the most common pancreatic cyst and a precursor of pancreatic cancer (PDAC). Since PDAC has a devastatingly high mortality rate, the early diagnosis and treatment of any precursor lesion are rational. The safety of the existing guidelines on the clinical management of IPMN has been criticized due to unsatisfactory sensitivity and specificity, showing the need for further markers. Blood obtained from patients with IPMN was therefore subjected to size-based isolation of circulating epithelial cells (CECs). We isolated CECs and evaluated their cytological characteristics. Additionally, we compared Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations in CECs and the primary IPMN tissue, since KRAS mutations are very typical for PDAC. Samples from 27 IPMN patients were analyzed. In 10 (37%) patients, CECs were isolated and showed a hybrid pattern of surface markers involving both epithelial and mesenchymal markers, suggesting a possible EMT process of the cells. Especially, patients with high-grade dysplasia in the main specimen were all CEC-positive. KRAS mutations were also present in CECs but less common than in IPMN tissue. The existence of CEC in IPMN patients offers additional blood-based research possibilities for IMPN biology.

Identifiants

pubmed: 37511945
pii: life13071570
doi: 10.3390/life13071570
pmc: PMC10381561
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Sci Rep. 2017 Jul 3;7(1):4510
pubmed: 28674438
Nat Rev Cancer. 2009 Apr;9(4):302-12
pubmed: 19308069
EBioMedicine. 2019 Aug;46:133-149
pubmed: 31375425
Surgery. 2012 Sep;152(3 Suppl 1):S4-12
pubmed: 22770958
Cancers (Basel). 2021 Dec 18;13(24):
pubmed: 34944983
Pancreatology. 2017 Mar - Apr;17(2):255-262
pubmed: 28189431
Virchows Arch. 2005 Nov;447(5):794-9
pubmed: 16088402
Histopathology. 2015 Sep;67(3):368-77
pubmed: 25641082
Pancreatology. 2012 May-Jun;12(3):183-97
pubmed: 22687371
JAMA. 2016 May 3;315(17):1882-93
pubmed: 27139061
Histopathology. 2020 Jan;76(2):182-188
pubmed: 31433515
Pancreatology. 2017 Sep - Oct;17(5):738-753
pubmed: 28735806
Pancreas. 2017 Aug;46(7):943-947
pubmed: 28697136
HPB (Oxford). 2018 Jun;20(6):497-504
pubmed: 29486917
Cancers (Basel). 2019 Mar 21;11(3):
pubmed: 30901891
Nat Rev Mol Cell Biol. 2008 Jul;9(7):517-31
pubmed: 18568040
Nat Rev Cancer. 2010 Oct;10(10):683-95
pubmed: 20814421
J Mol Diagn. 2020 Jul;22(7):943-956
pubmed: 32376474
Gastroenterology. 2012 Apr;142(4):730-733.e9
pubmed: 22226782
Lancet Oncol. 2019 Nov;20(11):1493-1505
pubmed: 31521509
Anticancer Res. 2020 Oct;40(10):5679-5685
pubmed: 32988893
Cancer Cytopathol. 2017 May;125(5):332-340
pubmed: 28257167
N Engl J Med. 2004 Sep 16;351(12):1218-26
pubmed: 15371579
Gastroenterology. 2014 Mar;146(3):647-51
pubmed: 24333829
Cell. 2012 Jan 20;148(1-2):349-61
pubmed: 22265420
HPB (Oxford). 2020 May;22(5):660-669
pubmed: 31786054
Pancreas. 2015 May;44(4):547-50
pubmed: 25822154
Pancreatology. 2021 Jan;21(1):103-114
pubmed: 33309014
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Pancreatology. 2006;6(1-2):17-32
pubmed: 16327281
Tumour Biol. 2016 Jun;37(6):7547-54
pubmed: 26684803
Oncologist. 2018 Jan;23(1):121-127
pubmed: 28860411
Ann Surg Oncol. 2014 Dec;21 Suppl 4:S750-7
pubmed: 25069861
Clin Gastroenterol Hepatol. 2016 Apr;14(4):585-593.e3
pubmed: 26370569

Auteurs

Jasmina Kuvendjiska (J)

Faculty of Medicine, Albert-Ludwigs-University of Freiburg, 79110 Freiburg im Breisgau, Germany.
Department of General and Visceral Surgery, University Medical Center Freiburg, 79106 Freiburg im Breisgau, Germany.

Felix Müller (F)

Faculty of Medicine, Albert-Ludwigs-University of Freiburg, 79110 Freiburg im Breisgau, Germany.

Peter Bronsert (P)

Faculty of Medicine, Albert-Ludwigs-University of Freiburg, 79110 Freiburg im Breisgau, Germany.
Tumorbank, Comprehensive Cancer Center Freiburg, University Medical Center Freiburg, 79106 Freiburg im Breisgau, Germany.
Institute for Surgical Pathology, University Medical Center Freiburg, 79106 Freiburg im Breisgau, Germany.

Sylvia Timme-Bronsert (S)

Faculty of Medicine, Albert-Ludwigs-University of Freiburg, 79110 Freiburg im Breisgau, Germany.
Tumorbank, Comprehensive Cancer Center Freiburg, University Medical Center Freiburg, 79106 Freiburg im Breisgau, Germany.
Institute for Surgical Pathology, University Medical Center Freiburg, 79106 Freiburg im Breisgau, Germany.

Stefan Fichtner-Feigl (S)

Faculty of Medicine, Albert-Ludwigs-University of Freiburg, 79110 Freiburg im Breisgau, Germany.
Department of General and Visceral Surgery, University Medical Center Freiburg, 79106 Freiburg im Breisgau, Germany.

Birte Kulemann (B)

Faculty of Medicine, Albert-Ludwigs-University of Freiburg, 79110 Freiburg im Breisgau, Germany.
Department of Surgery, University Medical Center Schleswig-Holstein, 23538 Lübeck, Germany.

Classifications MeSH